Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | D-1553 |
Trade Name | |
Synonyms | D1553|D 1553|garsorasib |
Drug Descriptions |
D-1553 (garsorasib) inhibits KRAS G12C, which potentially results in decreased tumor growth (Cancer Res 2021;81(13_Suppl):Abstract nr 932, PMID: 36948246). |
DrugClasses | KRAS G12C inhibitor 34 |
CAS Registry Number | 2559761-14-5 |
NCIT ID | C178562 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
BI 853520 + D-1553 | BI 853520 D-1553 | 0 | 0 |
Carboplatin + D-1553 | Carboplatin D-1553 | 0 | 0 |
Cetuximab + D-1553 | Cetuximab D-1553 | 0 | 0 |
Cisplatin + D-1553 | Cisplatin D-1553 | 0 | 0 |
D-1553 | D-1553 | 0 | 1 |
D-1553 + Oxaliplatin | D-1553 Oxaliplatin | 0 | 0 |
D-1553 + RMC-4550 | D-1553 RMC-4550 | 0 | 0 |
D-1553 + Trametinib | D-1553 Trametinib | 0 | 0 |